Detalles de la búsqueda
1.
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study.
Eur J Haematol
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654611
2.
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study.
Lancet Oncol
; 22(1): 142-154, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301738
3.
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries.
Ann Hematol
; 98(4): 941-949, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30729281
4.
Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.
Radiographics
; 39(4): 1077-1097, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31283452
5.
Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment.
Blood
; 127(6): 713-21, 2016 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26631116
6.
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
Br J Haematol
; 179(1): 66-74, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653400
7.
Observational study of multiple myeloma in Latin America.
Ann Hematol
; 96(1): 65-72, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815724
8.
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Lancet Oncol
; 15(11): 1195-206, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242045
9.
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.
Lancet Haematol
; 10(10): e801-e812, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793771
10.
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
Clin Lymphoma Myeloma Leuk
; 23(3): e171-e181, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641358
11.
Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma.
Am J Hematol
; 87(10): 948-52, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22730113
12.
Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE.
Cancer Chemother Pharmacol
; 57(5): 624-30, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16133527
13.
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial.
Lancet Haematol
; 3(11): e506-e515, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27751707
14.
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma.
Expert Rev Anticancer Ther
; 15(7): 737-48, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26051506
15.
Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
Leuk Res
; 27(2): 147-53, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12526920
16.
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
Cancer Chemother Pharmacol
; 53(1): 51-60, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14574458
17.
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia.
Med Oncol
; 31(3): 851, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24469953
18.
Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma.
Haematologica
; 93(5): 791-2, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18450738
19.
Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients.
Clinics (Sao Paulo)
; 66(11): 1855-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22086513
20.
Autologous stem cell transplantation improves quality of life in economically challenged, brazilian multiple myeloma patients
Clinics
; 66(11): 1855-1859, 2011. ilus, tab
Artículo
en Inglés
| LILACS | ID: lil-605863